- Company Overview for BLUE REG PHARMA CONSULTING LIMITED (09642951)
- Filing history for BLUE REG PHARMA CONSULTING LIMITED (09642951)
- People for BLUE REG PHARMA CONSULTING LIMITED (09642951)
- More for BLUE REG PHARMA CONSULTING LIMITED (09642951)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
17 Sep 2024 | GAZ2(A) | Final Gazette dissolved via voluntary strike-off | |
02 Jul 2024 | GAZ1(A) | First Gazette notice for voluntary strike-off | |
21 Jun 2024 | DS01 | Application to strike the company off the register | |
02 Oct 2023 | SH19 |
Statement of capital on 2 October 2023
|
|
02 Oct 2023 | SH20 | Statement by Directors | |
02 Oct 2023 | CAP-SS | Solvency Statement dated 28/09/23 | |
02 Oct 2023 | RESOLUTIONS |
Resolutions
|
|
18 Sep 2023 | AA | Total exemption full accounts made up to 31 December 2022 | |
28 Jul 2023 | TM01 | Termination of appointment of Christopher James Colton as a director on 31 March 2023 | |
28 Jul 2023 | AP01 | Appointment of Mr Laurent Maurice Robert Couston as a director on 31 March 2023 | |
28 Jul 2023 | AP01 | Appointment of Mr Christopher Gauglitz as a director on 31 March 2023 | |
13 Jun 2023 | CS01 | Confirmation statement made on 13 June 2023 with updates | |
21 Dec 2022 | TM01 | Termination of appointment of Corinne Schmitz as a director on 23 September 2022 | |
21 Dec 2022 | TM01 | Termination of appointment of Effexim as a director on 23 September 2022 | |
21 Dec 2022 | AP01 | Appointment of Mr Jonathan William Smithson Jeffery as a director on 23 September 2022 | |
21 Dec 2022 | AP01 | Appointment of Mr Christopher James Colton as a director on 23 September 2022 | |
23 Jun 2022 | CS01 | Confirmation statement made on 17 June 2022 with updates | |
14 Apr 2022 | AA | Total exemption full accounts made up to 31 December 2021 | |
21 Jun 2021 | CS01 | Confirmation statement made on 17 June 2021 with updates | |
20 May 2021 | AA | Total exemption full accounts made up to 31 December 2020 | |
27 Apr 2021 | TM01 | Termination of appointment of Paul Anthony Kuiken as a director on 26 April 2021 | |
26 Feb 2021 | CH02 | Director's details changed for Effexim on 1 January 2021 | |
11 Jul 2020 | CS01 | Confirmation statement made on 17 June 2020 with no updates | |
26 Jun 2020 | AA | Total exemption full accounts made up to 31 December 2019 | |
09 Sep 2019 | CH01 | Director's details changed for Corinne Schmitz on 9 September 2019 |